capsaicin has been researched along with Peripheral Nerve Diseases in 76 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (3.95) | 18.7374 |
1990's | 15 (19.74) | 18.2507 |
2000's | 28 (36.84) | 29.6817 |
2010's | 25 (32.89) | 24.3611 |
2020's | 5 (6.58) | 2.80 |
Authors | Studies |
---|---|
Alsalem, M; Barakat, NA; El-Salem, K; Haddad, M; Jaffal, SM; Saleh, T | 1 |
Gestosa, SVS; Lares, AMG; Mulenas, NME; Ruivo, EFM | 1 |
Cabezón-Gutiérrez, L; Custodio-Cabello, S; Khosravi-Shahi, P; Palka-Kotlowska, M | 1 |
Barkai, O; Binshtok, AM; Butterman, R; Katz, B; Lev, S | 1 |
Baron, R; Diel, I; Maihöfner, C; Quandel, T; Tesch, H | 1 |
Cull-Candy, SG; Farrant, M; Sullivan, SJ | 1 |
Beitz, AJ; Kim, SJ; Kwon, SG; Lee, JH; Roh, DH; Yeo, JH; Yoon, SY | 1 |
Jäger-Becker, D | 1 |
Yosipovitch, G | 1 |
Brown, S; Simpson, DM; Tobias, JK; Vanhove, GF | 1 |
Heskamp, ML; Maihofner, C | 1 |
Anderson, MJ; Christiansen, BA; Genetos, DC; Heffner, MA; Yeh, GC | 1 |
Bogdanovich, A; Busquets, C; Faulí, A; Giménez-Milà, M; Hernández-Cera, C; Moreno, LA; Navarro, MA; Ojeda, A; Videla, S | 1 |
Brenaut, E; Castela, E; Erfan, N; Lacour, JP; Lantéri-Minet, M; Misery, L; Passeron, T | 1 |
Erlandson, M; Legerski, P; Onysko, M; Potthoff, J | 1 |
Burness, CB; McCormack, PL | 1 |
Fehrenbacher, JC; Gracias, NG; Pittman, SK | 1 |
Bentley, A; Mankowski, C; Patel, S; Poole, C; Trueman, D | 1 |
Şavk, E | 1 |
Adler, JE; Skoff, AM; Zhao, C | 1 |
Babbar, S; Beliveau, M; Bley, K; Chanda, S; Marier, JF; Mouksassi, MS; Vanhove, GF | 1 |
Keppel Hesselink, JM; Kopsky, DJ | 1 |
Coderre, TJ; Kumar, N; Laferriere, A; Poon, T; Yu, JS | 1 |
Brown, S; Gazda, S; Lu, SP; Simpson, DM; Tobias, JK; Vanhove, GF; Webster, LR | 1 |
Baron, R; Mahn, F | 1 |
McCormack, PL | 1 |
Cherry, CL; Cox, S; Marshall, SJ; Phillips, TJ; Rice, AS | 1 |
Chapman, H; Hao, B; Huang, JL; Koivisto, A; Kuokkanen, K; Pertovaara, A; Saarnilehto, M; Wang, YX; Wei, H | 1 |
Lu, B; Murphy, FT; Peppin, JF; Tobias, JK; Vanhove, GF; Webster, LR | 1 |
Benemei, S; Creminon, C; Fusi, C; Geppetti, P; Materazzi, S; Nassini, R; Nilius, B; Patacchini, R; Pedretti, P; Prenen, J | 1 |
Gibbons, CH; Illigens, BM | 1 |
Chapman, V; Kelly, S | 1 |
Liu, XJ; Sawynok, J; White, TD | 1 |
Fox, AJ; McIntyre, P; Medhurst, SJ; Panesar, M; Patel, S; Urban, L; Walker, KM | 1 |
Li, GD; Zhao, ZQ; Zhou, Y | 1 |
Atweh, SF; Bach, JF; Dardenne, M; Jabbur, SJ; Saadé, NE; Safieth-Garabedian, B | 1 |
Magerl, W; Treede, RD | 1 |
Kempler, P | 1 |
Freeman, R | 1 |
Lonovics, J; Németh, J; Peitl, B; Porszasz, R; Sári, R; Sziklai, I; Szilvássy, J; Szilvássy, Z | 1 |
Bynum, T; Eisenach, JC; Hayashida, KI; Vincler, M | 1 |
Brower, JB; Casano, AR; Herman, JH; Herman, RM; Stoddard, DG; Targovnik, JH; Tearse, P | 1 |
Bromberg, MB; Herrmann, DN | 1 |
Hahn, K; Hauer, P; McArthur, JC; Polydefkis, M; Triolo, A | 1 |
Furue, H; Hasegawa, S; Inoue, K; Ishii, S; Koizumi, S; Masuda, T; Nagata, K; Nakamura, K; Shimizu, T; Tozaki-Saitoh, H; Tsuda, M; Yamashita, T; Yoshimura, M | 1 |
Abbott, L; Aschenbrenner, J; Collins, M; Hart, C; Visovsky, C | 1 |
Cheepudomwit, T; Griffin, JW; Güzelsu, E; Höke, A; Zhou, C | 1 |
Chiang, H; Hsieh, ST; Hsieh, YL; Tseng, TJ | 1 |
Hwang, SJ; Kim, E; Kim, J; Kim, SM; Lee, SE; Shin, HK | 1 |
Anand, P; Anand, U; Birch, R; Bountra, C; Chessell, I; Otto, WR; Sinisi, M | 1 |
Thomas, PK | 1 |
Campbell, JN; Cervero, F; Meyer, RA | 1 |
Epstein, JB; Marcoe, JH | 1 |
Cole, JD; Treede, RD | 1 |
Dyck, PJ; Litchy, WJ; Low, PA; O'Brien, PC; Opfer-Gehrking, TL | 1 |
Emanuele, MA; Emanuele, NV | 1 |
De Mey, JG; Jacobs, MJ; Kitslaar, PJ; Kurvers, HA; Reneman, RS; Rouwet, EV; Slaaf, DW; Tangelder, GJ; van den Wildenberg, FA | 1 |
Flores, CM; Harding-Rose, C; Hargreaves, KM; Kilo, S | 1 |
Huang, HT; Lo, YK | 1 |
Formaglio, F; Lauritano, D; Salvato, A; Spadari, F; Zambellini Artini, M | 1 |
Aloe, L; Lundeberg, T; Manni, L; Tirassa, P | 1 |
Ferrans, CE; Lashley, FR; Paice, JA; Pitrak, D; Shott, S; Vizgirda, V | 1 |
McCleane, G | 1 |
Kennedy, WR; Khalili, N; Simone, DA; Wendelschafer-Crabb, G | 1 |
Yonehara, N; Yoshimura, M | 1 |
Hama, AT | 1 |
Baumgärtner, U; Hopf, HC; Klein, T; Magerl, W; Treede, RD | 1 |
Ollat, H | 1 |
Harkness, DH; Larson, AA; Skilling, SR | 1 |
Abelli, L; Astolfi, M; Conte, B; Dahl, D; Ferri, GL; Geppetti, P; Maggi, CA; Parlani, M; Polak, JM | 1 |
Rumsfield, JA; West, DP | 1 |
Dubner, R | 1 |
Cotton, P | 1 |
Hartung, HP; Heininger, K; Toyka, KV | 1 |
Helme, RD | 1 |
17 review(s) available for capsaicin and Peripheral Nerve Diseases
Article | Year |
---|---|
High-Dose 8% Capsaicin Patch in Treatment of Chemotherapy-Induced Peripheral Neuropathy. A Systematic Review.
Topics: Antineoplastic Agents; Capsaicin; Humans; Peripheral Nervous System Diseases; Prospective Studies; Retrospective Studies; Transdermal Patch | 2020 |
Chemotherapy-induced peripheral neuropathy (CIPN): current therapies and topical treatment option with high-concentration capsaicin.
Topics: Capsaicin; Humans; Neoplasms; Peripheral Nervous System Diseases; Quality of Life | 2021 |
[Capsaicin (QUTENZA), dermatological use].
Topics: Administration, Topical; Capsaicin; Humans; Peripheral Nervous System Diseases | 2014 |
Targeting neuropathic pain: consider these alternatives.
Topics: Acetylcarnitine; Capsaicin; Complementary Therapies; Family Practice; gamma-Linolenic Acid; Humans; Magnesium; Neuralgia; Peripheral Nervous System Diseases; Thioctic Acid; Vitamin B Complex | 2015 |
Capsaicin 8 % Patch: A Review in Peripheral Neuropathic Pain.
Topics: Capsaicin; Diabetic Neuropathies; Humans; Neuralgia, Postherpetic; Pain Management; Peripheral Nervous System Diseases; Pregabalin; Sensory System Agents; Transdermal Patch | 2016 |
Neurologic Itch Management.
Topics: Acupuncture Therapy; Amines; Anesthetics, Local; Anticonvulsants; Antipruritics; Botulinum Toxins, Type A; Calcineurin Inhibitors; Cannabinoid Receptor Agonists; Capsaicin; Cyclohexanecarboxylic Acids; Doxepin; Gabapentin; gamma-Aminobutyric Acid; Humans; Neuromuscular Agents; Peripheral Nervous System Diseases; Phototherapy; Physical Therapy Modalities; Pregabalin; Pruritus; Tacrolimus; Transcranial Magnetic Stimulation; Transcutaneous Electric Nerve Stimulation | 2016 |
Capsaicin dermal patch: in non-diabetic peripheral neuropathic pain.
Topics: Administration, Cutaneous; Capsaicin; Dose-Response Relationship, Drug; Humans; Peripheral Nervous System Diseases; Sensory System Agents | 2010 |
Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials.
Topics: Analgesics; Anti-Retroviral Agents; Cannabis; Capsaicin; HIV Infections; Humans; Nerve Growth Factor; Peripheral Nervous System Diseases; Placebos; Plant Extracts; Randomized Controlled Trials as Topic; Research Design; Risk; Treatment Outcome | 2010 |
[Treatment of neuropathies].
Topics: Adjuvants, Immunologic; Capsaicin; Diabetic Neuropathies; Diagnosis, Differential; Humans; Liver Diseases; Peripheral Nervous System Diseases; Randomized Controlled Trials as Topic; Thiamine; Treatment Outcome | 2004 |
The treatment of neuropathic pain.
Topics: Anti-Arrhythmia Agents; Anticonvulsants; Antidepressive Agents, Tricyclic; Capsaicin; Diabetes Mellitus, Type 2; Humans; Neuralgia, Postherpetic; Nociceptors; Peripheral Nervous System Diseases; Selective Serotonin Reuptake Inhibitors; Sodium Channels | 2005 |
Putting evidence into practice: evidence-based interventions for chemotherapy-induced peripheral neuropathy.
Topics: Acetylcarnitine; Acupuncture Therapy; Anticonvulsants; Antidepressive Agents, Tricyclic; Antineoplastic Agents; Antioxidants; Calcium; Capsaicin; Evidence-Based Medicine; Exercise Therapy; Glutamine; Glutathione; Humans; Infrared Rays; Magnesium; Neoplasms; Nurse's Role; Nursing Research; Oncology Nursing; Patient Education as Topic; Peripheral Nervous System Diseases; Research Design; Sensory System Agents; Transcutaneous Electric Nerve Stimulation; Vitamin E | 2007 |
The peripheral nervous system as a target for toxic substances.
Topics: 6-Aminonicotinamide; Age Factors; Animals; Axons; Capsaicin; Demyelinating Diseases; Diphtheria Toxin; Doxorubicin; Humans; Methylmercury Compounds; Mice; Myelin Sheath; Neurons; Peripheral Nervous System Diseases; Rats; Schwann Cells; Vincristine | 1984 |
Drugs to treat the tissue complications of diabetes: peripheral neuropathy.
Topics: Administration, Topical; Analgesics; Antidepressive Agents, Tricyclic; Capsaicin; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Forecasting; Humans; Pain Threshold; Peripheral Nervous System Diseases | 1995 |
[Etiopathogenic, clinical-diagnostic and therapeutic aspects of the burning mouth syndrome. Research and treatment protocols in a patient group].
Topics: Adult; Aged; Analgesics; Benzodiazepines; Burning Mouth Syndrome; Capsaicin; Female; Humans; Male; Middle Aged; Mouth Mucosa; Peripheral Nervous System Diseases; Polyneuropathies; Tongue | 1998 |
[Pharmacological treatment of neuropathic pain].
Topics: Anesthetics, Local; Anticonvulsants; Antidepressive Agents; Baclofen; Capsaicin; Chronic Disease; Diabetic Neuropathies; Humans; Narcotics; Neuralgia; Pain; Peripheral Nervous System Diseases | 1992 |
Topical capsaicin in dermatologic and peripheral pain disorders.
Topics: Administration, Topical; Capsaicin; Humans; Pain; Peripheral Nervous System Diseases; Skin Diseases | 1991 |
[Neuromuscular manifestations of HIV-1 and HTLV-I infections].
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adrenal Cortex Hormones; Capsaicin; Carbamazepine; Demyelinating Diseases; Ganciclovir; HIV-1; HTLV-I Infections; Humans; Muscular Diseases; Neuritis; Neuromuscular Diseases; Peripheral Nervous System Diseases; Polyneuropathies; Zidovudine | 1988 |
12 trial(s) available for capsaicin and Peripheral Nerve Diseases
Article | Year |
---|---|
[In process].
Topics: Administration, Cutaneous; Capsaicin; Diabetic Neuropathies; Double-Blind Method; Humans; Neuralgia; Peripheral Nervous System Diseases | 2016 |
NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: results of a 52-week open-label study.
Topics: Adult; Capsaicin; Double-Blind Method; Endpoint Determination; Female; HIV Infections; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neuralgia; Neurologic Examination; Pain Management; Pain Measurement; Patient Satisfaction; Peripheral Nervous System Diseases; Sensory Receptor Cells; Skin; Transdermal Patch; Treatment Outcome | 2014 |
Prospective, non-interventional study on the tolerability and analgesic effectiveness over 12 weeks after a single application of capsaicin 8% cutaneous patch in 1044 patients with peripheral neuropathic pain: first results of the QUEPP study.
Topics: Administration, Cutaneous; Analgesics; Capsaicin; Female; Humans; Male; Middle Aged; Neuralgia; Pain Management; Peripheral Nervous System Diseases; Transdermal Patch; Treatment Outcome | 2013 |
Pharmacokinetic analysis of capsaicin after topical administration of a high-concentration capsaicin patch to patients with peripheral neuropathic pain.
Topics: Administration, Cutaneous; Administration, Topical; Capsaicin; Capsicum; Dosage Forms; Dose-Response Relationship, Drug; Female; Half-Life; HIV Infections; HIV-1; Humans; Kinetics; Male; Pain; Pain Measurement; Peripheral Nervous System Diseases; Treatment Outcome | 2009 |
Efficacy, safety, and tolerability of NGX-4010, capsaicin 8% patch, in an open-label study of patients with peripheral neuropathic pain.
Topics: Aged; Anesthetics, Local; Capsaicin; Diabetic Neuropathies; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Neuralgia, Postherpetic; Pain; Peripheral Nervous System Diseases; Polyneuropathies; Sensory System Agents; Transdermal Patch; Treatment Outcome | 2011 |
A psychophysical study of secondary hyperalgesia: evidence for increased pain to input from nociceptors.
Topics: Adult; Animals; Capsaicin; Cold Temperature; Double-Blind Method; Humans; Hyperalgesia; Injections, Intradermal; Male; Mechanoreceptors; Nociceptors; Pain Threshold; Peripheral Nervous System Diseases; Physical Stimulation; Wool | 1994 |
Topical application of capsaicin for treatment of oral neuropathic pain and trigeminal neuralgia.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Burning Mouth Syndrome; Capsaicin; Facial Pain; Female; Humans; Male; Middle Aged; Peripheral Nervous System Diseases; Toothache; Treatment Outcome; Trigeminal Neuralgia | 1994 |
Double-blind, placebo-controlled study of the application of capsaicin cream in chronic distal painful polyneuropathy.
Topics: Adult; Aged; Autonomic Nervous System Diseases; Capsaicin; Double-Blind Method; Female; Humans; Male; Middle Aged; Nerve Fibers; Neuralgia; Ointments; Peripheral Nervous System Diseases; Placebos; Sweat | 1995 |
Topical capsaicin in the management of HIV-associated peripheral neuropathy.
Topics: Administration, Topical; Adult; Capsaicin; Double-Blind Method; Female; HIV Infections; Humans; Male; Middle Aged; Palliative Care; Peripheral Nervous System Diseases; Treatment Failure | 2000 |
Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study.
Topics: Administration, Topical; Adult; Antidepressive Agents, Tricyclic; Capsaicin; Chronic Disease; Double-Blind Method; Doxepin; Female; Humans; Male; Middle Aged; Pain; Pain Measurement; Paresthesia; Peripheral Nervous System Diseases | 2000 |
Influence of thermode size for detecting heat pain dysfunction in a capsaicin model of epidermal nerve fiber loss.
Topics: Adult; Aged; Biopsy; Capsaicin; Epidermis; Female; Hot Temperature; Humans; Male; Middle Aged; Nerve Degeneration; Nerve Fibers; Nerve Regeneration; Pain Threshold; Peripheral Nervous System Diseases; Sensitivity and Specificity; Thiolester Hydrolases; Ubiquitin Thiolesterase | 2001 |
Compliance problems, placebo effect cloud trials of topical analgesic.
Topics: Capsaicin; Clinical Trials as Topic; Diabetic Neuropathies; Double-Blind Method; HIV Infections; Humans; Ointments; Patient Compliance; Peripheral Nervous System Diseases; Placebo Effect | 1990 |
47 other study(ies) available for capsaicin and Peripheral Nerve Diseases
Article | Year |
---|---|
Interaction of the synthetic cannabinoid WIN55212 with tramadol on nociceptive thresholds and core body temperature in a chemotherapy-induced peripheral neuropathy pain model.
Topics: Analgesics; Animals; Antineoplastic Agents; Body Temperature; Calcium; Cannabinoids; Capsaicin; Ganglia, Spinal; Male; Nociception; Pain; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Tramadol | 2023 |
Peripheral Neuropathy Associated with Hypereosinophilic Syndrome: A Clinical Therapeutic Success with Capsaicin 8% Patch.
Topics: Capsaicin; Humans; Hypereosinophilic Syndrome; Male; Middle Aged; Neuralgia; Pain Management; Peripheral Nervous System Diseases; Quality of Life; Transdermal Patch | 2020 |
The Input-Output Relation of Primary Nociceptive Neurons is Determined by the Morphology of the Peripheral Nociceptive Terminals.
Topics: Action Potentials; Capsaicin; Computer Simulation; Humans; Models, Neurological; Neuralgia; Nociception; Nociceptors; Peripheral Nerves; Peripheral Nervous System Diseases; Presynaptic Terminals; Sensory Receptor Cells; Sodium Channels; Synaptic Transmission | 2020 |
TARP γ-2 Is Required for Inflammation-Associated AMPA Receptor Plasticity within Lamina II of the Spinal Cord Dorsal Horn.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Calcium Channels; Capsaicin; Excitatory Amino Acid Agonists; Excitatory Postsynaptic Potentials; Female; Inflammation; Male; Mice; Mice, Inbred C57BL; Nerve Fibers, Unmyelinated; Neuronal Plasticity; Peripheral Nervous System Diseases; Posterior Horn Cells; Receptors, AMPA; Synaptic Transmission | 2017 |
Differential Development of Facial and Hind Paw Allodynia in a Nitroglycerin-Induced Mouse Model of Chronic Migraine: Role of Capsaicin Sensitive Primary Afferents.
Topics: Animals; Capsaicin; Cold Temperature; Diterpenes; Drug Resistance; Facial Nerve Diseases; Hindlimb; Hot Temperature; Hyperalgesia; Male; Mice, Inbred C57BL; Mice, Knockout; Migraine Disorders; Nerve Tissue Proteins; Neurons, Afferent; Neurotoxins; Nitric Oxide Donors; Nitroglycerin; Organ Specificity; Peripheral Nervous System Diseases; Sensory System Agents; TRPV Cation Channels | 2018 |
The 8% capsaicin - a hot medicine for neuropathic itch.
Topics: Antipruritics; Capsaicin; Humans; Nerve Fibers; Peripheral Nervous System Diseases; Pruritus; TRPV Cation Channels | 2018 |
Altered bone development in a mouse model of peripheral sensory nerve inactivation.
Topics: Animals; Bone and Bones; Bone Development; Capsaicin; Mice; Mice, Inbred C57BL; Nerve Degeneration; Peripheral Nervous System Diseases; Sensory System Agents; Tomography, X-Ray Computed | 2014 |
Assessment of the feasibility of high-concentration capsaicin patches in the pain unit of a tertiary hospital for a population of mixed refractory peripheral neuropathic pain syndromes in non-diabetic patients.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Analgesics; Capsaicin; Feasibility Studies; Female; Humans; Male; Middle Aged; Peripheral Nervous System Diseases; Prospective Studies; Tertiary Care Centers; Time Factors; Transdermal Patch; Treatment Outcome | 2014 |
Successful treatment of refractory neuropathic pruritus with capsaicin 8% patch: a bicentric retrospective study with long-term follow-up.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Antipruritics; Capsaicin; Female; France; Humans; Middle Aged; Peripheral Nervous System Diseases; Pruritus; Remission Induction; Retrospective Studies; Time Factors; Transdermal Patch; Treatment Outcome | 2015 |
Nerve growth factor alters microtubule targeting agent-induced neurotransmitter release but not MTA-induced neurite retraction in sensory neurons.
Topics: Animals; Antineoplastic Agents; Calcitonin Gene-Related Peptide; Capsaicin; Epothilones; Ganglia, Spinal; Male; Microtubules; Nerve Growth Factor; Neurites; Neuropeptides; Neurotransmitter Agents; Paclitaxel; Peripheral Nervous System Diseases; Potassium; Rats; Rats, Sprague-Dawley; Sensory Receptor Cells | 2016 |
Cost-Effectiveness of Capsaicin 8% Patch Compared with Pregabalin for the Treatment of Patients with Peripheral Neuropathic Pain in Scotland.
Topics: Administration, Topical; Analgesics; Capsaicin; Cost-Benefit Analysis; Humans; Peripheral Nervous System Diseases; Pregabalin; Scotland; Sensory System Agents | 2016 |
Interleukin-1alpha regulates substance P expression and release in adult sensory neurons.
Topics: Age Factors; Animals; Capsaicin; Cells, Cultured; Female; Ganglia, Spinal; Inflammation; Interleukin 1 Receptor Antagonist Protein; Interleukin-1alpha; Interleukin-1beta; Nerve Growth Factor; Neuralgia; Nociceptors; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Sensory Receptor Cells; Sensory System Agents; Substance P; Up-Regulation | 2009 |
A new combination cream for the treatment of severe neuropathic pain.
Topics: Administration, Topical; Analgesics; Capsaicin; Diabetic Neuropathies; Drug Combinations; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Ointments; Pain; Pain Measurement; Peripheral Nervous System Diseases; Pregabalin | 2010 |
Metabotropic glutamate receptors (mGluRs) regulate noxious stimulus-induced glutamate release in the spinal cord dorsal horn of rats with neuropathic and inflammatory pain.
Topics: Animals; Capsaicin; Glutamic Acid; Inflammation; Male; Pain; Pain Measurement; Peripheral Nervous System Diseases; Posterior Horn Cells; Rats; Rats, Long-Evans; Receptors, Metabotropic Glutamate | 2010 |
Long-term safety of NGX-4010, a high-concentration capsaicin patch, in patients with peripheral neuropathic pain.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Capsaicin; Female; HIV Infections; Humans; Male; Middle Aged; Neuralgia, Postherpetic; Pain; Peripheral Nervous System Diseases; Treatment Outcome; Young Adult | 2010 |
[Types of topical treatment for peripheral neuropathic pain : Mechanism of action and indications].
Topics: Administration, Topical; Afferent Pathways; Analgesics; Anesthetics, Local; Antidepressive Agents; Capsaicin; Humans; Lidocaine; Nerve Fibers; Nerve Regeneration; Neuralgia; Peripheral Nervous System Diseases; Sensory System Agents; TRPV Cation Channels | 2010 |
Spinal transient receptor potential ankyrin 1 channel contributes to central pain hypersensitivity in various pathophysiological conditions in the rat.
Topics: Acetanilides; Analysis of Variance; Animals; Ankyrins; Calcium Channels; Capsaicin; Cholecystokinin; Cinnamomum zeylanicum; Disease Models, Animal; Dose-Response Relationship, Drug; Formaldehyde; Hyperalgesia; Male; N-Methylaspartate; Pain Measurement; Peripheral Nervous System Diseases; Purines; Rats; Rats, Wistar; Sleep Deprivation; Spinal Cord; TRPA1 Cation Channel; TRPC Cation Channels | 2011 |
TRPA1 and TRPV4 mediate paclitaxel-induced peripheral neuropathy in mice via a glutathione-sensitive mechanism.
Topics: Acetanilides; Animals; Calcitonin Gene-Related Peptide; Capsaicin; Cold Temperature; Drug Hypersensitivity; Glutathione; Hyperalgesia; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Paclitaxel; Peripheral Nervous System Diseases; Purines; Pyrroles; Transient Receptor Potential Channels; TRPA1 Cation Channel; TRPV Cation Channels | 2012 |
A human model of small fiber neuropathy to study wound healing.
Topics: Adult; Biopsy; Capsaicin; Epidermis; Humans; Nerve Fibers; Peripheral Nervous System Diseases; Skin; Wound Healing; Young Adult | 2013 |
Effects of peripheral nerve injury on functional spinal VR1 receptors.
Topics: Action Potentials; Animals; Capsaicin; Denervation; Dose-Response Relationship, Drug; Down-Regulation; Hyperalgesia; Ligation; Nerve Fibers; Nerve Fibers, Myelinated; Neuralgia; Neuronal Plasticity; Nociceptors; Pain Threshold; Peripheral Nerve Injuries; Peripheral Nerves; Peripheral Nervous System Diseases; Physical Stimulation; Posterior Horn Cells; Rats; Receptors, Drug | 2002 |
Enhanced release of adenosine in rat hind paw following spinal nerve ligation: involvement of capsaicin-sensitive sensory afferents.
Topics: Adenosine; Adenosine Deaminase; Adenosine Deaminase Inhibitors; Adenosine Kinase; Afferent Pathways; Animals; Capsaicin; Disease Models, Animal; Enzyme Inhibitors; Hyperalgesia; Male; Nerve Crush; Nerve Fibers, Unmyelinated; Neuralgia; Neurons, Afferent; Nociceptors; Oxidopamine; Peripheral Nerve Injuries; Peripheral Nerves; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Skin; Spinal Nerves; Sympathetic Fibers, Postganglionic | 2002 |
The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and neuropathic pain.
Topics: Algorithms; Animals; Anticonvulsants; Capsaicin; Carbamazepine; Dose-Response Relationship, Drug; Guinea Pigs; Hyperalgesia; Inflammation; Male; Mice; Mice, Inbred C57BL; Peripheral Nervous System Diseases; Rats; Rats, Wistar; Receptors, Drug; Sciatic Nerve | 2003 |
State-dependent phosphorylation of epsilon-isozyme of protein kinase C in adult rat dorsal root ganglia after inflammation and nerve injury.
Topics: Animals; Behavior, Animal; Capsaicin; Carrageenan; Disease Models, Animal; Diterpenes; Freund's Adjuvant; Ganglia, Spinal; Hindlimb; Hyperalgesia; Inflammation; Ligation; Male; Neurons; Nociceptors; Pain; Pain Measurement; Peripheral Nervous System Diseases; Phosphorylation; Protein Kinase C; Protein Kinase C-epsilon; Rats; Rats, Sprague-Dawley; Receptors, Drug | 2003 |
A thymulin analogue peptide with powerful inhibitory effects on pain of neurogenic origin.
Topics: Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Capsaicin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Hot Temperature; Hyperalgesia; Ligation; Male; Meloxicam; Morphine; Pain; Pain Threshold; Peptides; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Reaction Time; Thiazines; Thiazoles; Thymic Factor, Circulating; Time Factors | 2003 |
Secondary tactile hypoesthesia: a novel type of pain-induced somatosensory plasticity in human subjects.
Topics: Adolescent; Adult; Afferent Pathways; Capsaicin; Female; Humans; Hypesthesia; Male; Mechanoreceptors; Middle Aged; Nerve Fibers, Unmyelinated; Neural Inhibition; Neuronal Plasticity; Neurons, Afferent; Nociceptors; Pain; Peripheral Nervous System Diseases; Presynaptic Terminals; Skin; Synaptic Transmission; Touch | 2004 |
Neurogenic insulin resistance in guinea-pigs with cisplatin-induced neuropathy.
Topics: Acetylcholine; Animals; Antineoplastic Agents; Atropine; Blood Glucose; Body Weight; Calcitonin Gene-Related Peptide; Capsaicin; Celiac Plexus; Cisplatin; Deoxyglucose; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glucose Clamp Technique; Guinea Pigs; Insulin; Insulin Resistance; Male; Muscle, Skeletal; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Peptide Fragments; Peripheral Nervous System Diseases; Vasodilator Agents | 2006 |
Inhibitory M2 muscarinic receptors are upregulated in both axotomized and intact small diameter dorsal root ganglion cells after peripheral nerve injury.
Topics: Animals; Axotomy; Behavior, Animal; Bethanechol; Calcium; Capsaicin; Cells, Cultured; Dose-Response Relationship, Drug; Drug Interactions; Functional Laterality; Gallamine Triethiodide; Ganglia, Spinal; Immunohistochemistry; Male; Muscarinic Agonists; Neural Inhibition; Neurons; Nicotinic Antagonists; Peripheral Nervous System Diseases; Potassium Chloride; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M2 | 2006 |
Prevalence of somatic small fiber neuropathy in obesity.
Topics: Adult; Age Factors; Body Mass Index; Capsaicin; Cross-Sectional Studies; Female; Glucose Tolerance Test; Hot Temperature; Humans; Hyperglycemia; Hyperinsulinism; Male; Middle Aged; Nerve Fibers; Obesity, Morbid; Peripheral Nervous System Diseases; Reaction Time; Regional Blood Flow; Sensation Disorders; Skin; Transcutaneous Electric Nerve Stimulation | 2007 |
Chili peppers, nerve regeneration, and clinical trial design.
Topics: Biomarkers; Biopsy; Capsaicin; Capsicum; Clinical Trials as Topic; Diabetic Neuropathies; HIV Infections; Humans; Nerve Fibers, Unmyelinated; Nerve Regeneration; Peripheral Nervous System Diseases; Sensory Receptor Cells; Treatment Outcome | 2007 |
Impaired reinnervation in HIV infection following experimental denervation.
Topics: Adult; Analgesics, Non-Narcotic; Antiretroviral Therapy, Highly Active; Apolipoprotein E4; Biomarkers; Capsaicin; Denervation; Female; Genetic Predisposition to Disease; Genetic Testing; HIV Infections; Humans; Male; Nerve Regeneration; Peripheral Nervous System Diseases; Predictive Value of Tests; Sensory Receptor Cells; Skin | 2007 |
Reduced pain behaviors and extracellular signal-related protein kinase activation in primary sensory neurons by peripheral tissue injury in mice lacking platelet-activating factor receptor.
Topics: Animals; Behavior, Animal; Capsaicin; Cell Count; Enzyme Inhibitors; Excitatory Postsynaptic Potentials; Extracellular Signal-Regulated MAP Kinases; Formaldehyde; Ganglia, Spinal; Male; Membrane Potentials; Mice; Mice, Knockout; Neurons, Afferent; Pain; Pain Measurement; Patch-Clamp Techniques; Peripheral Nervous System Diseases; Physical Stimulation; Platelet Membrane Glycoproteins; Reaction Time; Receptors, G-Protein-Coupled | 2007 |
Comparison of cytokine expression profile during Wallerian degeneration of myelinated and unmyelinated peripheral axons.
Topics: Animals; Axotomy; Capsaicin; Chemokine CCL2; Chemotaxis, Leukocyte; Cytokines; Disease Models, Animal; Ectodysplasins; Interleukin-10; Interleukin-1beta; Interleukin-2; Interleukin-6; Leukemia Inhibitory Factor; Macrophages; Male; Nerve Fibers, Myelinated; Nerve Fibers, Unmyelinated; Neurotoxins; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Schwann Cells; Up-Regulation; Wallerian Degeneration | 2008 |
Enhancement of cutaneous nerve regeneration by 4-methylcatechol in resiniferatoxin-induced neuropathy.
Topics: Animals; Calcitonin Gene-Related Peptide; Capsaicin; Catechols; Disease Models, Animal; Diterpenes; Drug Interactions; Ganglia, Spinal; Hyperalgesia; Male; Mice; Mice, Inbred ICR; Nerve Fibers, Unmyelinated; Nerve Regeneration; Neural Conduction; Neuroprotective Agents; Peripheral Nervous System Diseases; Reaction Time; Skin; Substance P; Ubiquitin Thiolesterase | 2008 |
Local application of capsaicin alleviates mechanical hyperalgesia after spinal nerve transection.
Topics: Analgesics; Animals; Biomarkers; Calcitonin Gene-Related Peptide; Capsaicin; Cell Count; Denervation; Ganglia, Spinal; Hyperalgesia; Male; Nerve Degeneration; Neuralgia; Neurons, Afferent; Pain Measurement; Peripheral Nerve Injuries; Peripheral Nerves; Peripheral Nervous System Diseases; Physical Stimulation; Rats; Rats, Sprague-Dawley; Sensory System Agents; TRPV Cation Channels | 2008 |
Cytosine arabinoside affects the heat and capsaicin receptor TRPV1 localisation and sensitivity in human sensory neurons.
Topics: Adult; Antimetabolites, Antineoplastic; Calcium; Capsaicin; Cell Division; Cell Membrane; Cell Survival; Cells, Cultured; Cytarabine; Dose-Response Relationship, Drug; Ganglia, Spinal; GAP-43 Protein; Humans; Ionomycin; Neurons, Afferent; Peripheral Nervous System Diseases; Sensory System Agents; Time Factors; TRPV Cation Channels | 2008 |
Dissociated secondary hyperalgesia in a subject with a large-fibre sensory neuropathy.
Topics: Adult; Capsaicin; Evoked Potentials; Humans; Hyperalgesia; Laser-Doppler Flowmetry; Male; Mechanoreceptors; Nerve Fibers; Neurons, Afferent; Nociceptors; Peripheral Nervous System Diseases | 1993 |
Skin blood flow disturbances in the contralateral limb in a peripheral mononeuropathy in the rat.
Topics: Animals; Capsaicin; Cold Temperature; Electric Stimulation; Functional Laterality; Hindlimb; Lidocaine; Male; Nerve Fibers; Neurons, Afferent; Pain; Peripheral Nervous System Diseases; Rats; Rats, Inbred Lew; Regional Blood Flow; Sciatic Nerve; Skin; Spinal Cord; Time Factors; Ultrasonography, Doppler; Vasoconstriction; Vasodilation | 1996 |
Peripheral CGRP release as a marker for neurogenic inflammation: a model system for the study of neuropeptide secretion in rat paw skin.
Topics: Animals; Basal Metabolism; Biomarkers; Calcitonin Gene-Related Peptide; Capsaicin; Disease Models, Animal; Hindlimb; Male; Nerve Endings; Neuritis; Neuropeptides; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Skin | 1997 |
A novel procedure for mediastinal vagotomy inhibits neurogenic inflammation in rat bronchial tree.
Topics: Animals; Axons; Bronchitis; Capillary Permeability; Capsaicin; Carbon; Coloring Agents; Evans Blue; Female; Mediastinum; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Recurrent Laryngeal Nerve; Vagotomy; Vagus Nerve | 1997 |
Cholecystokinin-8 enhances nerve growth factor synthesis and promotes recovery of capsaicin-induced sensory deficit.
Topics: Animals; Behavior, Animal; Calcitonin Gene-Related Peptide; Capsaicin; Male; Mice; Nerve Growth Factor; Neurons, Afferent; Pain Threshold; Peripheral Nervous System Diseases; RNA, Messenger; Sincalide; Substance P; Up-Regulation | 2000 |
Influence of capsaicin cream in rats with peripheral neuropathy.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Analgesics; Animals; Benzamides; Capsaicin; Carrageenan; Disease Models, Animal; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Hyperalgesia; Indoles; Isoindoles; Male; Neuroprotective Agents; Pain; Peripheral Nervous System Diseases; Piperidines; Postoperative Period; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Substance Withdrawal Syndrome; Time Factors | 2001 |
Capsaicin-sensitive primary afferents mediate responses to cold in rats with a peripheral mononeuropathy.
Topics: Animals; Cannabinoids; Capsaicin; Cold Temperature; Diterpenes; Hindlimb; Hyperalgesia; Ligation; Male; Mononeuropathies; Neurons, Afferent; Pain Measurement; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Sciatic Nerve | 2002 |
Neurogenic hyperalgesia versus painful hypoalgesia: two distinct mechanisms of neuropathic pain.
Topics: Adult; Aged; Capsaicin; Central Nervous System Diseases; Cold Temperature; Female; Hot Temperature; Humans; Hyperalgesia; Male; Middle Aged; Neuralgia; Neurons, Afferent; Pain Threshold; Peripheral Nervous System Diseases; Touch | 2002 |
Experimental peripheral neuropathy decreases the dose of substance P required to increase excitatory amino acid release in the CSF of the rat spinal cord.
Topics: Amino Acids; Animals; Animals, Newborn; Behavior, Animal; Capsaicin; Dialysis; Male; Nociceptors; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Spinal Cord; Substance P | 1992 |
Acrylamide-induced visceral neuropathy: evidence for the involvement of capsaicin-sensitive nerves of the rat urinary bladder.
Topics: Acrylamide; Acrylamides; Animals; Capsaicin; Male; Muscle, Smooth; Neurons, Afferent; Peripheral Nervous System Diseases; Rats; Rats, Inbred Strains; Urethra; Urinary Bladder; Urinary Retention | 1991 |
Topical capsaicin therapy for neuropathic pain.
Topics: Administration, Topical; Capsaicin; Humans; Pain; Peripheral Nervous System Diseases | 1991 |
Measurement of flare responses in patients with pain.
Topics: Adult; Aged; Capsaicin; Chronic Disease; Female; Humans; Male; Middle Aged; Nociceptors; Pain; Pain Measurement; Peripheral Nervous System Diseases | 1987 |